Ποια είναι η τιμή για Sangui Biotech International, Inc. (SGBI)

Η τιμή για Sangui Biotech International, Inc. (SGBI) είναι $0.0002

Ποια είναι η κεφαλαιοποίηση αγοράς για Sangui Biotech International, Inc. (SGBI)

Η κεφαλαιοποίηση αγοράς για Sangui Biotech International, Inc. (SGBI) είναι $41.98K

Sangui Biotech International, Inc. (SGBI) Τιμή και Κεφαλαιοποίηση Αγοράς

Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to humans experiencing acute or chronic oxygen deprivation due to conditions like blocked arteries, anemia, or blood loss, as well as for managing chronic wounds. Their product line also includes nano-formulations designed for skin regeneration, enhancing moisture and elasticity. Furthermore, they provide Chitoskin wound pads to aid in healing and Hemospray, a medical-grade spray specifically formulated for treating persistent wounds. The wound spray products, marketed under the Granulox brand, are primarily distributed in Europe and Mexico, while their cosmetic items are available through an online store. Established in 1995, Sangui Biotech International, Inc. is based in Hamburg, Germany.

Η τιμή για SGBI	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$25,927.66 $41.98K	NVDA	$5.442T	+12,963,831,603.51%
$21,263.78 $41.98K	AAPL	$4.463T	+10,631,889,660.58%
$19,844.14 $41.98K	GOOG	$4.165T	+9,922,068,598.37%
$17,529.99 $41.98K	MSFT	$3.680T	+8,764,996,608.98%
$13,668.79 $41.98K	AMZN	$2.869T	+6,834,396,963.14%

Η τιμή για SGBI

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$25,927.66 $41.98K